ORYZON to participate in upcoming events in November

Partners

Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events:

Fachada de las oficinas de Oryzon Genomics

30 October 2025

Corporate

Oryzon Genomics S.A.,(ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events:

BIO-EUROPE, November 3-5

Location: Viena Congress and Convention Center, Vienna, Austria

LSX Investival Showcase Europe 2025, November 17

Location: Old Billingsgate, London, United Kingdom

Jefferies Global Healthcare Conference, November 17-20

Location: Waldorf Hilton, London, United Kingdom

Oryzon management will be available for one-on-one meetings during the conferences.